• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Cancer Biomarkers Market – 2018-2023” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Sales Channel and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Cancer Biomarkers Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Cancer Biomarkers Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Market Size & Forecast

Global Cancer Biomarkers market witnessed a market value of USD XX Million in 2017 and is estimated to reach USD XX million in 2023, registering a compound annual growth rate (CAGR) of XX% between 2017 and 2023. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Market Segmentation
The research offers a comprehensive analysis of global Cancer Biomarkers market with respect to following sub-markets:

Based on Profiling Technology:
- Omic Technologies
- Imaging Technologies
- Immunoassays
- Cytogenetics Based Tests

Based on Biomolecules:
- Genetic Biomarkers
- Protein Biomarkers
- Glycoprotein Biomarkers

Based on Cancer Type:
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Other Cancers

Based on Application:
- Diagnostics
- Drug Discovery and Development
- Prognostics
- Risk Assessment
- Others

Competitive Landscape

The report also highlights the competitive landscape of the global Cancer Biomarkers market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Form development, research & development and other market activities).

The report includes profiles of leading companies in the global Cancer Biomarkers market.

Some of the key players profiled include:

- Allergan plc
- AstraZeneca plc
- Biocon Limited
- Chiasma, Inc.
- Proxima Concepts Limited (Diabetology Ltd.)
- Generex Biotechnology Corp.
- Novo Nordisk A/S.
- Synergy Pharmaceuticals Inc.
- Tarsa Therapeutics Inc.
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2017 – Base Year
- 2018 – Estimated Year
- 2019 to 2023 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Cancer Biomarkers Industry Report:

- What is the overall market size in 2017? What will be the market growth during the forecast period i.e. 2018-2023?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

Research Methodology
Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Cancer Biomarkers Market
3. Global Cancer Biomarkers Market Trends
4. Opportunities in Global Cancer Biomarkers Market
5. Recent Industry Activities, 2017
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Cancer Biomarkers Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9. Global Cancer Biomarkers Market Segmentation Analysis, By Profiling Technology
9.1. Introduction
9.2. Market Attractiveness, By Profiling Technology
9.3. BPS Analysis, By Profiling Technology
9.4. Omic Technologies Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5. Imaging Technologies Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.6. Immunoassays Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.7. Cytogenetics Based Tests Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

10. Global Cancer Biomarkers Market Segmentation Analysis, By Biomolecules
10.1. Introduction
10.2. Market Attractiveness, By Biomolecules
10.3. BPS Analysis, By Biomolecules
10.4. Genetic Biomarkers Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.5. Protein Biomarkers Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
10.6. Glycoprotein Biomarkers Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

11. Global Cancer Biomarkers Market Segmentation Analysis, By Cancer Type
11.1. Introduction
11.2. Market Attractiveness, By Cancer Type
11.3. BPS Analysis, By Cancer Type
11.4. Lung Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.5. Breast Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.6. Colorectal Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.7. Prostate Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.8. Stomach Cancer Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
11.9. Other Cancers Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

12. Global Cancer Biomarkers Market Segmentation Analysis, By Application
12.1. Introduction
12.2. Market Attractiveness, By Application
12.3. BPS Analysis, By Application
12.4. Diagnostics Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.5. Drug Discovery and Development Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.6. Prognostics Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.7. Risk Assessment Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
12.8. Others Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

13. Geographical Analysis
13.1. Introduction
13.2. North America Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.2.1. By Profiling Technology
13.2.2. By Biomolecules
13.2.3. By Cancer Type
13.2.4. By Application
13.2.5. By Country
13.2.5.1. Market Attractiveness, By End-use
13.2.5.2. BPS Analysis, By End-use
13.2.5.3. U.S. Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.2.5.4. Canada Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

13.3. Europe Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.1. By Profiling Technology
13.3.2. By Biomolecules
13.3.3. By Cancer Type
13.3.4. By Application
13.3.5. By Country
13.3.5.1. Market Attractiveness, By Country
13.3.5.2. BPS Analysis, By Country
13.3.5.3. Germany Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.5.4. United Kingdom Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.5.5. France Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.5.6. Italy Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.5.7. Spain Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.5.8. Russia Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.3.5.9. Rest of Europe Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

13.4. Asia Pacific Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.1. By Profiling Technology
13.4.2. By Biomolecules
13.4.3. By Cancer Type
13.4.4. By Application
13.4.5. By Country
13.4.5.1. Market Attractiveness, By Country
13.4.5.2. BPS Analysis, By Country
13.4.5.3. China Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.4. India Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.5. Japan Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.6. South Korea Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.7. Indonesia Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.8. Taiwan Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.9. Australia Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.10. New Zealand Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.4.5.11. Rest of Asia Pacific Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

13.5. Latin America Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.5.1. By Profiling Technology
13.5.2. By Biomolecules
13.5.3. By Cancer Type
13.5.4. By Application
13.5.5. By Country
13.5.5.1. Market Attractiveness, By Country
13.5.5.2. BPS Analysis, By Country
13.5.5.3. Brazil Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.5.5.4. Mexico Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.5.5.5. Rest of Latin America Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

13.6. Middle East & Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.6.1. By Profiling Technology
13.6.2. By Biomolecules
13.6.3. By Cancer Type
13.6.4. By Application
13.6.5. By Geography
13.6.5.1. Market Attractiveness, By Geography
13.6.5.2. BPS Analysis, By Geography
13.6.5.3. GCC Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.6.5.4. North Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.6.5.5. South Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
13.6.5.6. Rest of Middle East & Africa Market Size (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

14. Competitive Landscape
14.1. Market Share of Key Players
14.2. Market Positioning of Major Players in Global Cancer Biomarkers Market
14.3. Company Profiles
14.3.1. Allergan plc
14.3.1.1. Product Offered
14.3.1.2. Business Strategy
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.1.5. Market Share Analysis
14.3.1.6. Key Achievements & Developments
14.3.2. AstraZeneca plc
14.3.3. Biocon Limited
14.3.4. Chiasma, Inc.
14.3.5. Proxima Concepts Limited (Diabetology Ltd.)
14.3.6. Generex Biotechnology Corp.
14.3.7. Novo Nordisk A/S.
14.3.8. Synergy Pharmaceuticals Inc.
14.3.9. Tarsa Therapeutics Inc.

Select License Type
  • Single User License $3375 USD
  • Multi-User License $4275 USD
  • Corporate User License $5175 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients